MAPT and Alzheimer disease: Conversely, GLCMANNANAUT-PWY (the superpathway of N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminate degradation) was reversely associated with AD proxies and positively correlated with CSF p-tau levels as expected.